392 related articles for article (PubMed ID: 35663463)
1. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
[TBL] [Abstract][Full Text] [Related]
2. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
[TBL] [Abstract][Full Text] [Related]
3. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
[TBL] [Abstract][Full Text] [Related]
4. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
[TBL] [Abstract][Full Text] [Related]
5. Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.
Zhang L; Feng Z; Li Y; Lv C; Li C; Hu Y; Fu M; Song L
Front Microbiol; 2023; 14():1182346. PubMed ID: 37655344
[TBL] [Abstract][Full Text] [Related]
6. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
8. Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer.
Shah MS; DeSantis T; Yamal JM; Weir T; Ryan EP; Cope JL; Hollister EB
PLoS One; 2018; 13(11):e0207002. PubMed ID: 30412600
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people.
Li N; Bai C; Zhao L; Ge Y; Li X
Clin Transl Oncol; 2022 Jun; 24(6):1134-1147. PubMed ID: 35167015
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota shifts in patients with gastric cancer in perioperative period.
Liang W; Yang Y; Wang H; Wang H; Yu X; Lu Y; Shen S; Teng L
Medicine (Baltimore); 2019 Aug; 98(35):e16626. PubMed ID: 31464899
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
[TBL] [Abstract][Full Text] [Related]
13. Prediction model of poorly differentiated colorectal cancer (CRC) based on gut bacteria.
Qi Z; Zhibo Z; Jing Z; Zhanbo Q; Shugao H; Weili J; Jiang L; Shuwen H
BMC Microbiol; 2022 Dec; 22(1):312. PubMed ID: 36539710
[TBL] [Abstract][Full Text] [Related]
14. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
15. Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.
Liu W; Zhang R; Shu R; Yu J; Li H; Long H; Jin S; Li S; Hu Q; Yao F; Zhou C; Huang Q; Hu X; Chen M; Hu W; Wang Q; Fang S; Wu Q
Biomed Res Int; 2020; 2020():7828392. PubMed ID: 32083132
[TBL] [Abstract][Full Text] [Related]
16. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
17. Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling.
Thomas AM; Jesus EC; Lopes A; Aguiar S; Begnami MD; Rocha RM; Carpinetti PA; Camargo AA; Hoffmann C; Freitas HC; Silva IT; Nunes DN; Setubal JC; Dias-Neto E
Front Cell Infect Microbiol; 2016; 6():179. PubMed ID: 28018861
[TBL] [Abstract][Full Text] [Related]
18. Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer.
Luu K; Ye JY; Lagishetty V; Liang F; Hauer M; Sedighian F; Kwaan MR; Kazanjian KK; Hecht JR; Lin AY; Jacobs JP
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678187
[TBL] [Abstract][Full Text] [Related]
19. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
20. BRAF
Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
